Cargando…
Mutation Analysis of the BRCA1 and BRCA2 Genes in the Belgian Patient Population and Identification of a Belgian Founder Mutation BRCA1 IVS5+3A>G
Since the identification of the BRCA1 and BRCA2 genes, several hundred different germline mutations in both genes have been reported. Recurrent mutations are rare and mainly due to founder effects. As the mutational spectrum of the BRCA1 and BRCA2 genes in the Belgian patient population is largely u...
Autores principales: | Claes, Kathleen, Machackova, Eva, De Vos, Michel, Poppe, Bruce, De Paepe, Anne, Messiaen, Ludwine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851655/ https://www.ncbi.nlm.nih.gov/pubmed/10595255 http://dx.doi.org/10.1155/1999/241046 |
Ejemplares similares
-
BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families
por: Claes, K, et al.
Publicado: (2004) -
Founder BRCA1 mutations in Nepalese population
por: Mehta, Anurag, et al.
Publicado: (2022) -
Evidence of a founder BRCA1 mutation in Scotland
por: Liede, A, et al.
Publicado: (2000) -
BRCA1 founder mutations and ovarian cancer in Belarus
por: Savanevich, A, et al.
Publicado: (2015) -
The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel
por: Vazina, A, et al.
Publicado: (2000)